Insurance Untangles Ownership
After years of military life, Elizabeth and Stephen Allenbach were ready to settle down, so in 2002 they purchased a 100-year-old Victorian townhouse on Capitol Hill. But after they had been there for six months, a yellow summons arrived asserting a legal claim to title to the property.
Millions Not Joining Medicare Drug Plan
A $400 million campaign by the Bush administration to enroll low-income seniors in prescription drug coverage that would cost them just a few dollars per prescription has signed up 1.4 million people, a fraction of the 8 million eligible for the new coverage.
The Widening Economic Gap
What do you think about the widening gap in income in America? Do you think the rich can enjoy their riches without harming anyone?
Beating Debt with a Stick
Debt is a Product in America The #1 sickness in America concerning finances right now is debt. Debt is a product in our culture and it is vigorously aimed at you and me everyday, everywhere. As a society, we borrow more money than the last two ge…
It’s Time to Shake Out the Dust From Your Portfolio and Improve Its Efficiency
If your mutual fund portfolio hasn’t been performing as well as you think it should and you’re not sure why, it may be time for a bit of spring cleaning.
Solutions to Workforce Housing Problems Won’t Be Found in the Market Alone
A recent Washington Post (Feb. 7) Metro headline — “Cut in Planned Homes Dilutes an Urban Vision for Tysons” — summarized a report transcending both Tysons Corner and urban design. Written by Post staff writer Alec MacGillis, the story illuminates a systemic national problem: the challenge of…
One Size No Longer Fits FHA Borrowers
Should home buyers with solid credit histories subsidize borrowers who pay their bills late? Should loan applicants be separated into categories according to how likely they are to default, with the lowest-risk borrowers charged the lowest rates and fees?
Strategy Based on What’s Out of Favor
Vincent E. Gallagher and James K. Kloppenburg put together the second-best performance among U.S. growth mutual funds during the past decade by buying shares of companies in financial or regulatory turmoil.